Related Experiment Videos
Managing persistent hiccups in advanced cancer 2: treatment
1Ty Olwen Palliative Care Service, Morriston Hospital, Abertawe Bro Morgannwg University NHS Trust.
Nursing Times
|September 17, 2008
Summary
This study focuses on managing persistent hiccups in advanced cancer patients. It reviews non-drug and drug-based treatments to alleviate this common and distressing symptom.
Area of Science:
- Oncology
- Palliative Care
- Symptom Management
Background:
- Persistent hiccups are a distressing symptom in advanced cancer.
- Previous work covered incidence, causes, physiology, and adverse effects.
- Effective management strategies are crucial for patient quality of life.
Purpose of the Study:
- To review non-pharmacological interventions for persistent hiccups in advanced cancer.
- To examine pharmacological treatments for persistent hiccups in advanced cancer.
Main Methods:
- Literature review of non-pharmacological management strategies.
- Literature review of pharmacological interventions.
- Synthesis of evidence for treatment efficacy and safety.
Main Results:
- Non-pharmacological methods include behavioral techniques and physical maneuvers.
- Pharmacological options encompass various drug classes targeting hiccup pathways.
- Treatment selection depends on patient factors and symptom severity.
Conclusions:
- A multimodal approach combining non-pharmacological and pharmacological strategies is often necessary.
- Tailoring treatment to the individual patient is key for effective hiccup control.
- Further research may refine optimal management protocols for persistent hiccups.
Related Concept Videos
01:26Peptic Ulcer Disease IV: Management
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
01:29Gastroesophageal Reflux Disease II: Clinical Features and Management
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
01:21Barrett Esophagus-II: Clinical Manifestations and Management
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...